New drug trial targets COVID brain fog
NCT ID NCT05764538
Summary
This study is testing if a drug called DAOIB can help improve thinking, memory, and mood problems in people with long COVID. All 40 participants will take DAOIB for 24 weeks and have their symptoms checked regularly. The goal is to see if the treatment can ease the cognitive symptoms that persist after a COVID-19 infection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG COVID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kaohsiung Chang Gung Memorial Hospital
RECRUITINGKaohsiung City, 886, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.